Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/11388
Title: Epidemiology of inflammatory bowel disease in Málaga: incidence rate and follow-up of a cohort diagnosed between 2007-2008.
Authors: Cueto Torreblanca, Ignacio
Camargo Camero, Raquel
Andrade Bellido, Raúl
Romero Pérez, Eduardo
Alcaín Martínez, Guillermo
metadata.dc.subject.mesh: Adult
Age Factors
Cohort Studies
Colitis, Ulcerative
Crohn Disease
Female
Follow-Up Studies
Humans
Incidence
Inflammatory Bowel Diseases
Male
Middle Aged
Prospective Studies
Spain
Issue Date: 2017
Abstract: The incidence of inflammatory bowel disease (IBD) in Spain has been traditionally lower than in Northern European countries. Recent epidemiological studies have found that these differences are diminishing. This study estimates the incidence of IBD in Málaga (Spain), a city in Southern Spain and relates its results to those found in our neighboring countries. This was a prospective study designed to collect new cases diagnosed during the period from 2007-2008 and follow up these patients. Incidence is expressed as number of patients per 100,000 population per year. The population distribution found in the European Collaborative Study was used to standardize incidence rates. The gross incidence rate of IBD in Málaga is 9/105, the standardized incidence rate is 12.3/105 (9.7-15.6). These data are similar to those found in our surroundings, although a higher incidence rate for Crohn's disease (CD) as compared to ulcerative colitis (UC) was found. The clinical characteristics and outcomes of our patients do not differ significantly from those described for other populations.
URI: http://hdl.handle.net/10668/11388
metadata.dc.identifier.doi: 10.17235/reed.2017.4708/2016
ISSN: 1130-0108
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.


This item is protected by original copyright



Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.